Effectiveness of BufferGel as a Vaginal Contraceptive

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

975

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

April 30, 2005

Conditions
Pregnancy
Interventions
DRUG

BufferGel

Trial Locations (9)

10016

New York University, New York

10032

Columbia University, New York

15213

University of Pittsburgh, Pittsburgh

19104

University of Pennsylvania, Philadelphia

23507

Eastern Virginia Medical School, Norfolk

45267

University of Cincinnati, Cincinnati

80045

University of Colorado, Denver

Unknown

California Family Health Council, Berkeley

California Family Health Council, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Premier Research

OTHER